CYNTHIA ANTONIO
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family ORANGE, CA NPI 1962745554
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family CA Lilly USA, LLC All categories
General Payments — all program years on this page
$6,769.50
- Category: General Payments
- Program years: PY2021–2023
- Record count: 378
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $2,660.37 across 131 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,660.37 | 131 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $491.59 | 30 |
| MannKind Corporation | $308.71 | 17 |
| Embecta Corp. | $242.17 | 9 |
| Novo Nordisk AS | $194.60 | 13 |
| Amgen Inc. | $152.24 | 11 |
| CeQur Corporation | $146.06 | 1 |
| Horizon Pharma plc | $142.49 | 2 |
| ABBVIE INC. | $126.98 | 8 |
| Bayer HealthCare Pharmaceuticals Inc. | $112.59 | 4 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $103.93 | 5 |
| Kyowa Kirin, Inc. | $76.09 | 3 |
| Insulet Corporation | $68.20 | 3 |
| Radius Health, Inc. | $67.92 | 3 |
| Alexion Pharmaceuticals, Inc. | $62.07 | 3 |
| DEXCOM, INC. | $50.54 | 3 |
| PFIZER INC. | $47.49 | 2 |
| Acerta Pharma LLC | $40.71 | 2 |
| Tandem Diabetes Care, Inc. | $40.09 | 2 |
| Xeris Pharmaceuticals, Inc. | $38.71 | 2 |
| Abbott Laboratories | $38.27 | 2 |
| SANOFI-AVENTIS U.S. LLC | $32.74 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $24.65 | 1 |
| Halozyme Inc | $19.18 | 1 |
| IBSA Pharma Inc. | $19.15 | 1 |
| Merck Sharp & Dohme Corporation | $13.20 | 1 |
By program year
Records — PY2023 (131)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.